New theories in interstitial cystitis

被引:24
作者
Chai, Toby C.
Keay, Susan
机构
[1] Univ Maryland, Sch Med, Div Urol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Internal Med, Div Infect Dis, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Surg, Div Urol, Baltimore, MD 21201 USA
[4] VA Maryland Hlth Care Syst, Baltimore, MD USA
来源
NATURE CLINICAL PRACTICE UROLOGY | 2004年 / 1卷 / 02期
关键词
antiproliferative factor; bladder; interstitial cystitis; purinergic pathway; urothelial cells;
D O I
10.1038/ncpuro0057
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Interstitial cystitis (IC) is a chronic symptom-complex characterized by pathological sensation of the bladder (i.e. bladder pain in addition to augmented sensory signals such as urinary frequency and urgency) without evidence of bacterial cystitis or other identifiable lower urinary tract disease. Patients with IC typically describe feeling the urge to void frequently, as well as pain in the bladder and/or urethra. The painful sensation may be described as burning, pressure, sharp, or aching, and is often difficult for the patient to localize precisely. Multiple theories as to the cause of IC have been proposed with varying degrees of evidence. The current body of literature supports the idea that IC is associated with an intrinsic pathology of the bladder urothelial cells. The identification and complete characterization of antiproliferative factor (APF), which is uniquely expressed by urothelial cells in bladders affected by IC, are major advances in the understanding of IC. Additionally, urothelial cells have been likened to neurons because of their ability to express neuronal receptors and release neurotransmitters. The purinergic pathway has been shown to be upregulated in urothelial cells in bladders affected by IC. These new findings should help to direct the development of newer clinical treatments for IC. A complete understanding of IC will only be possible with parallel advances in both basic and clinical sciences.
引用
收藏
页码:85 / 89
页数:5
相关论文
共 48 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]   Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome - A randomized, double-blind trial [J].
Alexander, RB ;
Propert, KJ ;
Schaeffer, AJ ;
Landis, JR ;
Nickel, JC ;
O'Leary, MP ;
Pontari, MA ;
McNaughton-Collins, M ;
Shoskes, DA ;
Comiter, CV ;
Datta, NS ;
Fowler, JE ;
Nadler, RB ;
Zeitlin, SI ;
Knauss, JS ;
Wang, YL ;
Kusek, JW ;
Nyberg, LM ;
Litwin, MS .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (08) :581-589
[3]   Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1 [J].
Birder, LA ;
Nakamura, Y ;
Kiss, S ;
Nealen, ML ;
Barrick, S ;
Kanai, AJ ;
Wang, E ;
Ruiz, G ;
de Groat, WC ;
Apodaca, G ;
Watkins, S ;
Caterina, MJ .
NATURE NEUROSCIENCE, 2002, 5 (09) :856-860
[4]   Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder [J].
Birder, LA ;
Apodaca, G ;
De Groat, WC ;
Kanai, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (02) :F226-F229
[5]  
Birder LA, 2002, J NEUROSCI, V22, P8063
[6]  
Buffington CAT, 1997, J UROLOGY, V158, P786
[7]   Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction [J].
Burnstock, G .
JOURNAL OF ANATOMY, 1999, 194 :335-342
[8]   Percutaneous sacral third nerve root neurostimulation improves symptoms an D normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis [J].
Chai, TC ;
Zhang, CO ;
Warren, JW ;
Keay, S .
UROLOGY, 2000, 55 (05) :643-646
[9]   Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis [J].
Chai, TC ;
Zhang, CO ;
Shoenfelt, JL ;
Johnson, HW ;
Warren, JW ;
Keay, S .
JOURNAL OF UROLOGY, 2000, 163 (05) :1440-1444
[10]  
Chess-Williams R., 2002, Autonomic & Autacoid Pharmacology, V22, P133, DOI 10.1046/j.1474-8673.2002.00258.x